Life sciences companies face specific challenges throughout the discovery, development, and commercialisation processes, including exposure to a high degree of risk.
Increasingly stringent global regulations mean compliance must remain at the forefront of daily activities, and the penalty for violations goes beyond finances. Because life sciences companies' work largely involves human beings, trust and reputation management are critical aspects of their risk management plan.
Risk for life sciences companies comes from a number of angles. Whether it’s litigation regarding regulatory actions or intellectual property disputes, product liability claims, cyber theft, or supply chain disruptions, life sciences companies require a strong strategy for minimising risk as well as a solid plan for addressing situations that might arise.
Marsh’s experienced life sciences risk management team can help develop solutions relevant to your business and to your risks, whether you are in the pharmaceutical, biotechnology, medical device and supply, or contract research sector.
Featured insights
26/02/2025
The rise in litigation, liability and impact of PFAs
The growing concern about potential health and environmental risks linked to PFAs substances have led to an increase in lawsuits.
20/11/2024
Product and clinical trials liability webinar
Watch our Global Life Sciences Webinar for insights to navigate the dynamic insurance marketplace in the Life Sciences industry.
16/07/2024
Podcast: People in focus
Join Marsh and Mercer as they delve into the latest insights from Mercer's Global Talent Trends report and discuss how these findings impact the life sciences industry and its workforce.